Pre clinical and Clinical evaluation of KARAPPAN CHOORANAM (oral administration) and ERULI ENNAI (external application) in the management of Atopic dermatitis

Pre clinical and Clinical evaluation of the effect on oral administration of “KARAPPAN CHOORANAM? along with external application of “ERULI ENNAI? in the management of Pitha Karapan

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/03/040769

Enrollment

Registered

2022-03-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Karappan choornam(oral administration): 500mg – 1gm, (According to age of the patients) for 15 days after meals with hot water Intervention2: Eruli Ennai(External application): Topica

Eligibility

Inclusion criteria

Inclusion criteria: Frequent focusing for skin allergy Severe itching in skin Erythema in skin Vesicles in skin Oozing in skin

Exclusion criteria

Exclusion criteria: Children above 12 years Children below 3 years exacerbation of eczema eczema associated with systemic illness

Design outcomes

Secondary

Measure	Time frame
nilTimepoint: nil	—

Primary

Measure	Time frame
This study will help to understand the effects of KARAPPAN CHOORANAM and ERULI ENNAI in the management of PITHA KARAPPAN and may provide a better improvement in health care of children Timepoint: 15 days	—

Countries

India

Contacts

Public ContactDr K Shyamala

Government siddha medical college and hospital

shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026